Private Advisor Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216K | Hold |
1,150
| – | – | ﹤0.01% | 2416 |
|
|
2025
Q4 | $218K | Buy |
+1,150
| New | +$213K | ﹤0.01% | 2355 |
|
|
2025
Q1 | – | Sell |
-1,375
| Closed | -$216K | – | 2319 |
|
|
2024
Q4 | $216K | Sell |
1,375
-500
| -27% | -$84.1K | ﹤0.01% | 2050 |
|
|
2024
Q3 | $333K | Hold |
1,875
| – | – | ﹤0.01% | 1870 |
|
|
2024
Q2 | $316K | Hold |
1,875
| – | – | ﹤0.01% | 1846 |
|
|
2024
Q1 | $312K | Buy |
1,875
+200
| +12% | +$33.1K | ﹤0.01% | 1806 |
|
|
2023
Q4 | $277K | Hold |
1,675
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q3 | $261K | Buy |
1,675
+75
| +5% | +$12K | ﹤0.01% | 1723 |
|
|
2023
Q2 | $250K | Sell |
1,600
-11
| -0.7% | -$1.76K | ﹤0.01% | 1739 |
|
|
2023
Q1 | $261K | Buy |
+1,611
| New | +$261K | ﹤0.01% | 1649 |
|
|
2022
Q4 | – | Sell |
-1,600
| Closed | -$225K | – | 1692 |
|
|
2022
Q3 | $225K | Hold |
1,600
| – | – | ﹤0.01% | 1621 |
|
|
2022
Q2 | $233K | Sell |
1,600
-50
| -3% | -$7.45K | ﹤0.01% | 1764 |
|
|
2022
Q1 | $268K | Sell |
1,650
-215
| -12% | -$34.8K | ﹤0.01% | 1736 |
|
|
2021
Q4 | $353K | Sell |
1,865
-280
| -13% | -$54K | ﹤0.01% | 1636 |
|
|
2021
Q3 | $434K | Sell |
2,145
-236
| -10% | -$49.6K | ﹤0.01% | 1573 |
|
|
2021
Q2 | $480K | Sell |
2,381
-325
| -12% | -$60.5K | ﹤0.01% | 1412 |
|
|
2021
Q1 | $475K | Sell |
2,706
-200
| -7% | -$36.2K | ﹤0.01% | 1327 |
|
|
2020
Q4 | $493K | Hold |
2,906
| – | – | 0.01% | 1221 |
|
|
2020
Q3 | $471K | Hold |
2,906
| – | – | 0.01% | 1078 |
|
|
2020
Q2 | $473K | Sell |
2,906
-300
| -9% | -$45.6K | 0.01% | 1037 |
|
|
2020
Q1 | $410K | Hold |
3,206
| – | – | 0.01% | 958 |
|
|
2019
Q4 | $447K | Sell |
3,206
-79
| -2% | -$10.4K | 0.01% | 1103 |
|
|
2019
Q3 | $388K | Sell |
3,285
-1,720
| -34% | -$214K | 0.01% | 1176 |
|
|
2019
Q2 | $645K | Sell |
5,005
-680
| -12% | -$83.8K | 0.01% | 930 |
|
|
2019
Q1 | $730K | Sell |
5,685
-250
| -4% | -$31.6K | 0.01% | 812 |
|
|
2018
Q4 | $657K | Sell |
5,935
-698
| -11% | -$84.3K | 0.02% | 736 |
|
|
2018
Q3 | $902K | Buy |
+6,633
| New | +$863K | 0.02% | 733 |
|
|
2018
Q2 | – | Sell |
-6,160
| Closed | -$741K | – | 1304 |
|
|
2018
Q1 | $741K | Buy |
+6,160
| New | +$773K | 0.03% | 523 |
|
|
2017
Q4 | – | Sell |
-13,317
| Closed | -$1.8M | – | 1194 |
|
|
2017
Q3 | $1.8M | Buy |
13,317
+160
| +1% | +$20.8K | 0.04% | 396 |
|
|
2017
Q2 | $1.65M | Buy |
13,157
+8,405
| +177% | +$1.01M | 0.04% | 399 |
|
|
2017
Q1 | $558K | Buy |
4,752
+270
| +6% | +$31.6K | 0.02% | 773 |
|
|
2016
Q4 | $507K | Buy |
4,482
+1,845
| +70% | +$201K | 0.02% | 728 |
|
|
2016
Q3 | $302K | Buy |
2,637
+605
| +30% | +$69K | 0.01% | 824 |
|
|
2016
Q2 | $215K | Hold |
2,032
| – | – | 0.01% | 963 |
|
|
2016
Q1 | $211K | Sell |
2,032
-630
| -24% | -$65.7K | 0.01% | 894 |
|
|
2015
Q4 | $338K | Buy |
2,662
+55
| +2% | +$6.74K | 0.02% | 744 |
|
|
2015
Q3 | $298K | Buy |
+2,607
| New | +$345K | 0.02% | 737 |
|
|
2014
Q4 | – | Sell |
-510
| Closed | -$54K | – | 1017 |
|
|
2014
Q3 | $54K | Buy |
+510
| New | +$51.6K | ﹤0.01% | 1042 |
|
Other funds holding BBH
MIM
CCA
BFG
Private Advisor Group's BBH Position: Q1 2026 in Review
Private Advisor Group held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 1,150 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
Private Advisor Group first reported a position in BBH in Q3 2014 and has held it in 38 quarters since. The position peaked at $1.8M in Q3 2017. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Private Advisor Group held 1,150 shares of VanEck Biotech ETF worth $216K as of Q1 2026.
- Private Advisor Group left its VanEck Biotech ETF share count unchanged in Q1 2026.
- VanEck Biotech ETF made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2416 holding.
- Private Advisor Group first reported a position in VanEck Biotech ETF in Q3 2014 and has held it in 38 quarters since.
- Private Advisor Group's VanEck Biotech ETF position peaked at $1.8M in Q3 2017.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.